The Valley Desk

ArticleAmerican journal of hematologyPublished

Final Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCL

11 of 37 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
American journal of hematology
Published
Subject terms
Mantle Cell Lymphoma; Bruton Tyrosine Kinase Inhibitor; Pirtobrutinib; Non‐covalent Btki
PubMed ID
42983593
Added to directory
Source checked

Report a correction or request removal